Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by FactFinder1994on Dec 14, 2015 11:08am
57 Views
Post# 24382004

RE:RE:RE:RE:RE:How many more won't get a second chance

RE:RE:RE:RE:RE:How many more won't get a second chanceRoger - I see your character name was just created.... Over 100 North Americans EACH DAY DIE, who could otherwise potentially be living well if they had the benefit of PMX treatment. Given the BIG DATA that has been accumulated we now know that there is repeatable/predictable statistics with different forms of sepsis patients. Sepsis is a crisis, and PMX is making an impact in other developed countries already. PMX will be available commercially soon as the scale up of production in anticipation of pending approval happened earlier this year too. Look closer at the Ownership structure. There are clues there too. Approval could happen anytime given the great need and successful and safe profile of PMX.
Bullboard Posts